Skip to main content
Log in

CircPGPEP1 promotes the growth and metastasis of breast cancer cells by targeting miR-30b

  • Original Article
  • Published:
Molecular & Cellular Toxicology Aims and scope Submit manuscript

Abstract

Background

Circular RNAs (circRNAs) and microRNAs (miRNAs) are closely associated with tumorigenesis. Breast cancer is a heterogeneous disease with subtypes. It is one of the leading causes of death in women, and dysregulation of various circRNAs and miRNAs are involved in the development of breast cancer. Furthermore, circPGPEP1(hsa_circ_0050102) could function as a tumor promoter. However, the potential mechanisms of circPGPEP1-modulated signaling in breast cancer are still unknown.

Objective

The aim of this study was to identify the detailed roles of circPGPEP1 during tumor progression. The expression profiles of circPGPEP1 and miR-30b in breast cancer tissues and cells were examined using RT-qPCR. The protein levels of ITGB3 in MCF-7 and T47D cells transfected with miR-30b mimics were determined by western blotting. Additionally, the proliferation, invasion and migration of transfected breast cancer cells were evaluated using CCK8 and Transwell assays. Moreover, the apoptotic rates of treated cancer cells were measured by flow cytometry. Luciferase reporter assay was used to explore the interaction between miR-30b and circPGPEP1/ITGB3.

Results

Our results revealed upregulation of circPGPEP1 in breast cancer tissues and cell lines, which was associated with poor prognosis in the patients. Knockdown of circPGPEP1 inhibited the proliferation, invasion and migration of cancer cells, while cell apoptosis was promoted. The expression of miR-30b was increased but the levels of ITGB3 were decreased following the knockdown of circPGPEP1. Furthermore, miR-30b was negatively correlated with circPGPEP1 and ITGB3 in breast cancer tissues. In addition, miR-30b mimics suppressed the growth of breast cancer cells, whereas cell apoptosis was enhanced. These effects were reversed by the overexpression of ITGB3. Furthermore, miR-30b mimics could abrogate the biological behavior changes caused by oe-circPGPEP1.

Conclusion

CircPGPEP1 could function as a tumor promoter by targeting miR-30b and ITGB3. The circPGPEP1/miR-30b/ITGB3 axis may regulate the proliferation, invasion, migration and apoptosis of breast cancer cells, which could be novel prognostic and therapeutic target.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

The datasets generated during and/or analysed during the current study are available from the corresponding author upon reasonable request.

References

  • Adam-Artigues A, Garrido-Cano I, Simon S, Ortega B, Moragon S, Lameirinhas A, Constancio V, Salta S, Burgues O, Bermejo B, Henrique R, Lluch A, Jeronimo C, Eroles P, Cejalvo J (2021) Circulating miR-30b-5p levels in plasma as a novel potential biomarker for early detection of breast cancer. ESMO Open 6(1):100039

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Britt KL, Cuzick J, Phillips K (2020) Key steps for effective breast cancer prevention. Nat Rev Cancer 20:417–436

    Article  CAS  PubMed  Google Scholar 

  • Burstein HJ (2020) Systemic therapy for estrogen receptor-positive, HER2-negative breast cancer. New Engl J Med 383:2557–2570

    Article  CAS  PubMed  Google Scholar 

  • Croset M, Pantano F, Kan C, Bonnelye E, Descotes F, Alix-Panabieres c, Lecellier C, Bachelier R, Alllioli N, Hong S, Bartkowiak K, Pantel K, Clezardin P: miRNA-30 Family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes. Cancer Res 78: 5259-5273, 2018

  • Di Timoteo G, Dattilo D, Centrón-Broco A, Colantoni A, Guarnacci M, Rossi F, Incarnato D, Oliviero S, Fatica A, Morlando M, Bozzoni I (2020) Modulation of circRNA Metabolism by m6A Modification. CELL REP 31:107641

    Article  PubMed  Google Scholar 

  • Dubsky P, Pinker K, Cardoso F, Montagna G, Ritter M, Denkert C, Rubio I, Azambuja E, Curigliano G, Gentilini O, Gnant M, Gunthert A, Hauser N, Heil J, Knauer M, Knotek-Roggenbauerc M, Knox S, Kovacs T, Kuerer H, Loibl S, Mannhart M, Meattini I, Penault-Llorca F, Radosevic-Robin N, Sager P, Spanic T, Steyerova P, Tausch C, Peeters M, Weber W, Cardoso M (2021) Poortmans P : Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. Lancet Oncol 22:e18–e28

    Article  PubMed  Google Scholar 

  • Estevao-Pereira H, Lobo J, Salta S, Amorim M, Lopes P, Cantante M, Reis B, Antunes L, Castro F, Palma de Sousa S, Goncalves C, Costa B, Henrique R, Jeronimo C: Overexpression of circulating MiR-30b-5p identifies advanced breast cancer. J Trans Med 17(1): 435, 2019

  • Fuentes P, Sesé M, Guijarro P, Emperador M, Sanchez-Redondo S, Peinado H, Hummer S, Cajal S (2020) ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells. Nat Commun 11:4261

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Gao D, Zhou Z, Huang H (2019) miR-30b-3p inhibits proliferation and invasion of hepatocellular carcinoma cells via suppressing PI3K/Akt pathway. Front Genet 10:1247

    Article  Google Scholar 

  • Guan B, Li Q, Zhang H, Yang H (2021) circ_NOTCH3 Functions as a Protooncogene Competing With miR-205-5p, Modulating KLF12 Expression and Promoting the Development and Progression of Basal-Like Breast Carcinoma. FRONT ONCOL 10:602694

    Article  PubMed  PubMed Central  Google Scholar 

  • Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F (2019) Breast Cancer Nat Rev Dis Primers 5:66

    Article  PubMed  Google Scholar 

  • Hua S, Gao J, Li T, Wang M, You L, Chen G, Han X, Liao Q: The promoting effects of hsa_circ_0050102 in pancreatic cancer and the molecular mechanism by targeting miR-1182/NPSR1. CARCINOGENESIS, 2020.

  • Huang X, Huang Z, Huang J, Xu B, Huang X, Xu Y, Zhou J, Tang Z (2020) Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J Exp Clin Canc Res 39:20

    Article  CAS  Google Scholar 

  • Li Y, Song Y, Li P, Li M, Wang H, Xu T, Yu X, Yu Y, Tai Y, Chen P, Cai X, Wang X, Xiang L, Deng R, Zhang X, Gao L, Wang X, Liu J, Cao F (2019) Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma. J Immunother Cancer 8:e111

    Google Scholar 

  • Li X, Ding J, Wang X, Cheng Z, Zhu Q (2020) NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma. Oncogene 39:891–904

    Article  PubMed  Google Scholar 

  • Reich D, Kresinsky A, Müller JP, Bauer R, Kallenback J, Schnoeder T, Heidel F, Fassler R, Mann M, Bohmer F, Jayavelu A (2020) SHP1 regulates a STAT6–ITGB3 axis in FLT3ITD-positive AML cells. Leukemia 34:1444–1449

    Article  PubMed  Google Scholar 

  • Shafabakhsh R, Mirhosseini N, Chaichian S, Moazzami B, Mahdizadeh Z, Asemi Z (2019) Could circRNA be a new biomarker for pre-eclampsia? Mol Reprod Dev 86:1773–1780

    Article  CAS  PubMed  Google Scholar 

  • Shi Y, Jia X, Xu J (2020) The new function of circRNA: translation. Clin Transl Oncol 22:2162–2169

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Zhao X, Wang Y, Ren F, Sun D, Yan Y, Kong X, Bu J, Liu M, Xu S (2020) circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis 11:32

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang Y, Liu X, Wang L, Zhang Z, Li Z and Li M: Circ_PGPEP1 Serves as a Sponge of miR-1297 to Promote Gastric Cancer Progression via Regulating E2F3. DIGEST DIS SCI, 2021a.

  • Wang Y, Wang C, Fu Z, Zhang S, Chen J: miR-30b-5p inhibits proliferation, invasion, and migration of papillary thyroid cancer by targeting GALNT7 via the EGFR/PI3K/AKT pathway. Cancer cell international, 2021b.

  • Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng X, Xiong F, Guo C, Li Y, Li X, Li G, Zeng Z, Xiong W (2020a) Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA. Mol Cancer 19:22

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wu Q, Zhong H, Jiao L, Wen Y, Zhou Y, Zhou J, Lu X, Song X, Ying B (2020b) MiR-124-3p inhibits the migration and invasion of Gastric cancer by targeting ITGB3. Pathol—Res Practice 216:152762

    Article  CAS  Google Scholar 

  • Wu T, Song H, Xie D, Hua K, Hu J, Deng Y, Ji C, Fang L (2020c) Mir-30b-5p promotes proliferation, migration, and invasion of breast cancer cells via targeting ASPP2. Biomed Res Int 1–12:2020

    Google Scholar 

  • Xu J, Ji L, Liang Y, Wan Z, Zheng W, Song X, Gorshkov K, Sun Q, Lin H, Zheng X, Chen J, Jin R, Liang X, Cai X (2020) CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1. Signal Transduct Target Ther 5:298

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang Q, Liu S, Zhang J, Ma X, Dong M, Sun B, Xin Y: Roles and regulatory mechanisms of miR-30b in cancer, cardiovascular disease, and metabolic disorders (Review). Exp Therapeutic Med. 2020.

  • Zhang H, Ge Z, Wang Z, Gao Y, Wang Y and Qu X: Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p/STAT3 axis in breast cancer. Aging 13, 2021.

  • Zhou J, Xiang A, Guo J, Cui H (2019) miR-30b suppresses the progression of breast cancer through inhibition of the PI3K/Akt signaling pathway by targeting Derlin-1. Trans Cancer Res 8(1):180–190

    Article  CAS  Google Scholar 

  • Zhu C, Kong Z, Wang B, Cheng W, Wu A, Meng X (2019) ITGB3/CD61: a hub modulator and target in the tumor microenvironment. Am J Transl Res 11:7195–7208

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors express their sincere thanks to the seniors and colleagues for providing adequate guidance, scientific and technical discussions and necessary support for this research article. The first author and the co-author acclaim the reviewers and editor for their valuable comments and suggestions.

Funding

Not applicable.

Author information

Authors and Affiliations

Authors

Contributions

Both authors designed the study and carried out the experiments. They both analyzed the data and drafted the manuscript.

Corresponding author

Correspondence to Xiang Wang.

Ethics declarations

Conflict of interest

Yongjia Tan declares that she has no conflict of interest. Xiang Wang declares that he has no conflict of interest.

Ethical approval

This study was approved by the Ethics Committee of the Third Affiliated Hospital of Chongqing Medical University (Chongqing, China).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tan, Y., Wang, X. CircPGPEP1 promotes the growth and metastasis of breast cancer cells by targeting miR-30b. Mol. Cell. Toxicol. (2023). https://doi.org/10.1007/s13273-023-00376-9

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13273-023-00376-9

Keywords

Navigation